These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 2188826)

  • 21. A double-blind, controlled, multicenter, randomized study comparing the antihypertensive effectiveness and tolerance of a daily dose of two nifedipine formulations: nifedipine microgranules versus nifedipine osmotic pump.
    de Roa ER; Botero R; Octavio JA; Berrizbeitia ML; Mayorca E; Castro P; Miranda R; Valecillo E; Aroca G; Aza G; González M
    Am J Ther; 2007; 14(2):140-6. PubMed ID: 17414581
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative effectiveness of antihypertensive drugs prescribed in Ethiopian healthcare practice: A pilot prospective, randomized, open label study.
    Mengesha HG; Welegerima AH; Hadgu A; Temesgen H; Otieno MG; Tsegay K; Fisseha T; Getachew S; Merha Z; Tewodros H; Dabessa J; Gebreegzabher B; Petrucka P
    PLoS One; 2018; 13(9):e0203166. PubMed ID: 30204768
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enalapril and enalapril-hydrochlorothiazide in the treatment of essential hypertension. The Enalapril-Hydrochlorothiazide in Essential Hypertension Canadian Working Group.
    Clin Ther; 1993; 15(2):364-73. PubMed ID: 8519044
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative study on monotherapy with sustained-release diltiazem 300 mg and enalapril 20 mg in mild to moderate arterial hypertension.
    Fermé I; Djian J; Tcherdakoff P
    J Cardiovasc Pharmacol; 1990; 16 Suppl 1():S46-50. PubMed ID: 1706014
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A comparison of enalapril and metoprolol as initial therapy for mild to moderate hypertension.
    Nugent LW; Miola SR; Walker JF
    J Clin Pharmacol; 1987 Jul; 27(7):461-7. PubMed ID: 2821080
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Double-blind, parallel, comparative study on quality of life during treatment with amlodipine or enalapril in mild or moderate hypertensive patients: a multicentre study.
    Omvik P; Thaulow E; Herland OB; Eide I; Midha R; Turner RR
    J Hypertens; 1993 Jan; 11(1):103-13. PubMed ID: 8382234
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of hypertension by enalapril and hydrochlorothiazide separately and together: a multicenter study.
    Rosenthal T; Grossman E; Rathaus M; Bernheim J; Zevin D; Levi J; Weinstein J; Rogel S
    Isr J Med Sci; 1990 Feb; 26(2):63-6. PubMed ID: 2180849
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of domestic bisoprolol,enalapril and nifedipine retard in mild to moderate hypertension: a randomized double-blind multicenter clinical trial in China.
    Liu G; Li M; Shi X; Et Al
    Zhonghua Nei Ke Za Zhi; 2002 Jul; 41(7):450-2. PubMed ID: 12189112
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Atenolol plus nifedipine for mild to moderate systemic hypertension after fixed doses of either agent alone.
    Daniels AR; Opie LH
    Am J Cardiol; 1986 Apr; 57(11):965-70. PubMed ID: 3515899
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of enalapril and atenolol in mild to moderate hypertension.
    Herrick AL; Waller PC; Berkin KE; Pringle SD; Callender JS; Robertson MP; Findlay JG; Murray GD; Reid JL; Lorimer AR
    Am J Med; 1989 Apr; 86(4):421-6. PubMed ID: 2539017
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Atenolol and sustained release nifedipine alone and in combination in hypertension. A randomised, double-blind, crossover study.
    Anderton JL; Vallance BD; Stanley NN; Crowe PF; Mittra B; Perks WH
    Drugs; 1988; 35 Suppl 4():22-6. PubMed ID: 3288467
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of mild to moderate hypertension with or without the converting enzyme inhibitor enalapril. Results of a six-month double-blind trial.
    Sassano P; Chatellier G; Billaud E; Alhenc-Gelas F; Corvol P; Ménard J
    Am J Med; 1987 Aug; 83(2):227-35. PubMed ID: 3039842
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Equivalent reduction of proteinuria in hypertensives by either nifedipine GITS or enalapril: disparate effects on neurohormones and ambulatory blood pressure and the influence of salt.
    DeQuattro V; Lee DP
    Cardiology; 1997; 88 Suppl 3():38-42. PubMed ID: 9397292
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of the antihypertensive effects of delapril and enalapril.
    Rahn KH
    Am J Hypertens; 1991 Jan; 4(1 Pt 2):38S-41S. PubMed ID: 2009146
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prazosin GITS vs sustained release nifedipine in patients with hypertension and abnormal lipid profile: a randomized, controlled, multicenter study. Madras Hypertension Study Group.
    Misra KP; Joglekar SJ; Mukherjee S; Nanivadekar AS
    J Assoc Physicians India; 1998; Suppl 1():30-40. PubMed ID: 11233385
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enalapril, atenolol, and hydrochlorothiazide in mild to moderate hypertension. A comparative multicentre study in general practice in Norway.
    Helgeland A; Strømmen R; Hagelund CH; Tretli S
    Lancet; 1986 Apr; 1(8486):872-5. PubMed ID: 2870352
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Comparative and double-blind study of the efficacy and safety of cilazapril compared to nifedipine retard in the treatment of mild and moderate arterial hypertension].
    Velasco-Cornejo IF; Mion Júnior D; Martin LC; Tinucci T; Sampaio M; Pascoal IJ; Athanázio-Heliodoro RC; Marcondes M; Franco RJ
    Arq Bras Cardiol; 1994 Mar; 62(3):159-64. PubMed ID: 7980076
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A randomized, double-blind, parallel-group study to compare the anti-hypertensive effects of imidapril and nifedipine in the treatment of mild-to-moderate essential hypertension.
    van der Does R; Euler R
    J Int Med Res; 2001; 29(3):154-62. PubMed ID: 11471852
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lisinopril or nifedipine in essential hypertension? A Norwegian multicenter study on efficacy, tolerability and quality of life in 828 patients.
    Os I; Bratland B; Dahløf B; Gisholt K; Syvertsen JO; Tretli S
    J Hypertens; 1991 Dec; 9(12):1097-104. PubMed ID: 1663965
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term effects of angiotensin-converting enzyme inhibition and metabolic control in hypertensive type 2 diabetic patients.
    Chan JC; Ko GT; Leung DH; Cheung RC; Cheung MY; So WY; Swaminathan R; Nicholls MG; Critchley JA; Cockram CS
    Kidney Int; 2000 Feb; 57(2):590-600. PubMed ID: 10652036
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.